COMMUNIQUÉS West-GlobeNewswire

TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
16/09/2026
Expands New Jersey retail footprint to five dispensaries Dispensary generates over US$10 million in annualized revenue and will be immediately accretive to EBITDA and cash flow TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE [...]
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
16/09/2026
Founder of Zone School of Healing Uses the Zone Technique to Balance the Body’s Six Main Systems, Helping Clients Pursue Healing at the Highest Level BERKELEY, CA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- After nearly a [...]
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
16/09/2026
Groundbreaking synergy of DEL screening and computational chemistry yields the first compound to meet the TBXT Challenge’s submicromolar binding threshold for brachyury (TBXT) WALTHAM, Mass., Sept. 16, 2026 (GLOBE [...]
NEXGEL Announces Date for Investor Update Call
16/09/2026
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians [...]
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
16/09/2026
MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc. ("PetVivo"), in cooperation with its parent, PetVivo Holdings, Inc. (OTCQX: PETV), and its other subsidiaries, Somatrix Technologies, Inc. and [...]
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
16/09/2026
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. [...]
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
16/09/2026
Total national coverage footprint for PENFS increases to over 120 million covered lives CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
NeuroSigma Expands Payment Options for the Monarch eTNS® System
16/09/2026
Families prescribed Monarch can now pay with digital wallets or third-party installment plans at checkout LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced expanded payment options for [...]
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
16/09/2026
Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategy ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: [...]
Gautham Chidambaram Announces New QP & Half-Pound THCA Flower Sizing at Passion Farms
16/09/2026
Passion Farms just made it easier for wholesale buyers to try new strains-rolling out QP and half-pound THCA flower sizes across TX, CA & OK, no more pound minimums. HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- [...]
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
16/09/2026
DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) executives put even more personal capital behind the company, following positive Phase 2a results for its [...]
Major shareholder announcement - BlackRock, Inc.
16/09/2026
16 September 2026 ANNOUNCEMENT NO. 315 Major shareholder announcement - BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that [...]
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
16/09/2026
LA JOLLA, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that [...]
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
16/09/2026
New Preclinical PDAC Data for PRP Show >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Highlights How Reversing Epithelial-Mesenchymal Transition May Deepen & Extend Responses to RAS(ON [...]
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum
16/09/2026
Presentation Highlights Clinical Translation of ONP-002 Intranasal Delivery Platform for Concussion Treatment James P. Kelly, MD, Chief Medical Officer of Oragenics, is scheduled to present in the Successful Case [...]
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
16/09/2026
Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies THE WOODLANDS, TX [...]
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
16/09/2026
Sessions will highlight Orchestra BioMed's collaboration with Medtronic and explore the potential for AVIM Therapy to treat hypertensive heart disease in pacemaker-indicated patients and beyond NEW HOPE, Pa., Sept. 16, [...]
A.D.A.M. Innovations Expands GeneAI Forecast With New Chronic Disease Risk Assessment Models and Connected Biomarker Integration
16/09/2026
New models for asthma, atopic dermatitis and chronic obstructive pulmonary disease (COPD) expand GeneAI Forecast to 18 conditions, alongside resting heart rate integration from health apps and wearable devices. TOKYO, [...]
DLH Secures Follow-On NHLBI IT Services Award Valued at Up to $43.7 Million
16/09/2026
ATLANTA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today [...]

Pages

Other news

Promaxo Announces Closing of Series C Financing and $100M Credit Facility

Contenu:

The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings

ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update

Contenu:

WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp.

BreathiZen Introduces BreathiZen Spray - A New Multi-Ingredient Dietary Supplement For Your Respiratory Wellness

Contenu:

BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine.

New York, Oct. 22, 2026 (GLOBE NEWSWIRE) --

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026

Contenu:

Company to host conference call on November 5, 2026, at 4:30 p.m. ET

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

Contenu:

PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

Contenu:

Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

Contenu:

TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc.